Diseases of the brain are on the rise globally as a result of population growth, demographic shifts and increases in lifespan. Between these diseases, epilepsy is one of the most common serious neurological disorders that affects all ages across the globe. Epilepsy is a disease characterized by recurrent seizures associated with abnormal electrical activity in the brain. Around 1% of the population suffers from epilepsy and current treatments have several drawbacks.
Epilepsy is characterized by abnormal, synchronized bursts of electrical activity in the brain. Antiseizure medication is the first-line treatment, but one third of patients are not seizure free with currently available drugs. Thanks to the need to find alternative techniques, neuromodulation has emerged as one of the most promising alternatives to treat not just epilepsy but many other neurological disorders.
At 4Brain, we focus our epilepsy research in neuromodulation, researching a wide range of techniques that modulate neural activity both invasively and non-invasively. Our work focuses on understanding how different neuromodulation approaches interact with neural tissue, and we do this by combining our deep expertise in neuroscience along with an engineering-driven design.
Discover different Neuromodulation techniques researched at 4Brain
Discover our latest brain cancer related publications here.
Meet our epilepsy researchers at 4BRAIN:
-
Paul Boon
Professor Paul Boon, MD, PhD, is a neurologist at Ghent University Hospital. He leads a multidisciplinary research team that focuses on unraveling complex brain mechanisms in order to develop new therapies for the most common neurological disorders. The research4Brain research team wants to make a difference for the ever-growing group of people living with brain disorders.
-
Robrecht Raedt
Professor Robrecht Raedt, PhD, is leading the preclinical 4Brain research lab, with a main focus on new treatment techniques as a treatment for various neuropsychiatric disorders (epilepsy, stroke, multiple sclerosis, glioblastoma).
-
-
Evelien Carrette
Evelien Carrette, PhD is policy officer and research coordinator at the Neurology department including 4BRAIN within the department of Head & Skin. Her expertise lays within the field of MEG specifically and the presurgical evaluation of patients with refractory epilepsy in general. She is involved in a lot of the neuromodulatory research at 4BRAIN.ย
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
